The Bertarelli Program in Translational Neuroscience and Neuroengineering, a collaborative program between Harvard Medical School and the École Polytechnique Fédérale de Lausanne in Switzerland, has announced a new set of grants worth $3.6 million for five research projects.
While most colleges and universities in the National Collegiate Athletic Association have created programs to help diagnose and treat concussions sustained by their athletes, many are not fully meeting the NCAA’s standards, according to new research.
A new form of gene therapy for boys with the life-threatening condition known as “bubble boy” disease appears to be both effective and safe, according to an international clinical trial run by a team from Harvard Medical School, Dana-Farber/Boston Children's Cancer and Blood Disorders Center, and other institutions.
Harvard stem cell researchers announced a giant leap forward in the quest to find a truly effective treatment for type 1 diabetes, a disease that affects an estimated 3 million Americans.
Research led by Harvard investigators has found six new genes underlying coffee-drinking behavior.
A Harvard study finds that reduced resident work hours mandated by 2003 national reforms have not led to lower-quality physicians completing residency, as measured by hospital length of stay and inpatient mortality.
The Dallas Ebola case was a black eye for emergency room workers who sent a Liberian man home even though they were told he had just arrived from the epidemic zone. But the case could act as a wake-up call for emergency workers around the country, panelists say.
Three nonprofits with strong Harvard ties have joined forces at the front lines of the Ebola epidemic in West Africa.
A study led by Harvard-affiliated researchers is the first to demonstrate that BET bromodomain-containing proteins help execute inflammation in the endothelium while inhibition of BET bromodomain can significantly decrease atherosclerosis in vivo.
In an advance against cancer metastasis, scientists at the Harvard-affiliated Dana-Farber Cancer Institute have shown that a specially developed compound can impede multiple myeloma in mice from spreading to the bones.
Sign up for daily emails with the latest Harvard news.
Six Harvard Medical School (HMS) researchers were among the recipients of the 2014 António Champalimaud Vision Award, the highest distinction in ...
Bangladesh has used stepped-up surveillance, an understanding of transmission routes, and expert advice on cultural and traditional practices to devise interventions against Nipah, an Ebola-like virus with a high mortality rate.
Panelists at the School of Public Health called for a stronger communications effort by physicians to counter misinformation on vaccines.
Harvard researchers working at the Broad Institute of MIT and Harvard have uncovered nine rare genetic mutations that dramatically increase the risk of developing type 2 diabetes. The discovery of the mutations highlights the dizzying genetic diversity of a disease rapidly spreading around the world.
A Harvard Stem Cell Institute study comparing how blood stem cells and leukemia cells consume nutrients found that cancer cells are far less tolerant of shifts in their energy supply than their normal counterparts. The results suggest there could be ways to target and kill cancer cells without affecting healthy cells.
The fight to end the Ebola epidemic is not just about saving lives, it’s also about heading off a potentially broader humanitarian crisis, according to a Harvard Kennedy School panel.
For 30 years, the Victims of Violence program at Harvard-affiliated Cambridge Health Alliance has been a force in trauma care.
Harvard scientists have developed a new test for sickle cell disease that provides results in just 12 minutes and costs as little as 50 cents — far faster and cheaper than other tests.
Dietary quality in the United States has improved steadily in recent years, but overall dietary quality remains poor and disparities continue to widen among socioeconomic and racial/ethnic groups, according to a new study from the Harvard School of Public Health.
A team of researchers from the Broad Institute, Harvard University, and elsewhere has sequenced and analyzed dozens of Ebola virus genomes in the present outbreak. Their findings could have important implications for rapid field diagnostic tests.